Jon Jones

Author PubWeight™ 23.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 2010 3.66
2 Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasis. Cancer Biol Ther 2010 1.53
3 CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia 2006 1.52
4 Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm. Urology 2012 1.46
5 4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner. J Immunol 2002 1.29
6 Diagnosis and surgical management of colovesical fistulas due to sigmoid diverticulitis. J Urol 2009 1.23
7 Robotic technology and the translation of open radical prostatectomy to laparoscopy: the early Frankfurt experience with robotic radical prostatectomy and one year follow-up. Eur Urol 2003 1.15
8 RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis. Mol Cancer Ther 2008 1.13
9 Pathway analysis of high-throughput biological data within a Bayesian network framework. Bioinformatics 2011 1.00
10 Incidence, clinical symptoms and management of rectourethral fistulas after radical prostatectomy. J Urol 2009 0.99
11 Single center comparison of anastomotic strictures after radical perineal and radical retropubic prostatectomy. Urology 2009 0.95
12 Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells. BMC Cancer 2009 0.94
13 Renal transplantation in the elderly: surgical complications and outcome with special emphasis on the Eurotransplant Senior Programme. Nephrol Dial Transplant 2008 0.94
14 Human cytomegalovirus infection alters PC3 prostate carcinoma cell adhesion to endothelial cells and extracellular matrix. Neoplasia 2006 0.91
15 CXC chemokine mRNA expression as a potential diagnostic tool in prostate cancer. Mol Med Rep 2011 0.87
16 Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection. J Immunol 2007 0.87
17 Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro. BJU Int 2009 0.85
18 Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis. Bone 2010 0.84
19 Altered expression of beta1 integrins in renal carcinoma cell lines exposed to the differentiation inducer valproic acid. Int J Mol Med 2006 0.83
20 Association of intravesical tumor location with metastases to the pelvic lymph nodes in transitional cell cancer of the bladder. Am J Med Sci 2010 0.77
21 Intraoperative peripheral frozen sections do not significantly affect prognosis after nerve-sparing radical prostatectomy for prostate cancer. BJU Int 2010 0.77
22 Incidence of Cardiovascular Events after Nephrectomy - A Single Centre, Matched Pair Analysis between Donor and Tumour Nephrectomy in a Long Term Follow-Up. Urol Int 2016 0.75
23 Autocrine stimulation of human hepatocytes triggers late DNA synthesis and stabilizes long-term differentiation in vitro. Int J Mol Med 2008 0.75
24 Stabilization of CeO(2) nanoparticles in a CO(2) rich solvent. Chem Commun (Camb) 2008 0.75
25 Effect of procurement-related organ lesions on renal transplant outcome. Clin Transplant 2008 0.75